DLEU2 modulates proliferation, migration and invasion of platelet-derived growth factor-BB (PDGF-BB)-induced vascular smooth muscle cells (VSMCs) via miR-212-5p/YWHAZ axis

References

• Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011 Mar;12(3):204–212. PubMed PMID: 21321594.
   PubMed Web of Science ®Google Scholar
• Frostegard J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013 May 1;11:117. PubMed PMID: 23635324; PubMed Central PMCID: PMCPMC3658954.
   PubMed Web of Science ®Google Scholar
• Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016 Feb 19;118(4):692–702. PubMed PMID: 26892967; PubMed Central PMCID: PMCPMC4762053.
   PubMed Web of Science ®Google Scholar
• Majesky MW. Vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2016 Oct;36(10):e82–6. PubMed PMID: 27655780; PubMed Central PMCID: PMCPMC5102260.
   PubMedGoogle Scholar
• Grootaert MOJ, Moulis M, Roth L, et al. Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis. Cardiovasc Res. 2018 Mar 15;114(4):622–634. PubMed PMID: 29360955.
   PubMed Web of Science ®Google Scholar
• Hu D, Yin C, Luo S, et al. Vascular smooth muscle cells contribute to atherosclerosis immunity. Front Immunol. 2019;10:1101. PubMed PMID: 31164888; PubMed Central PMCID: PMCPMC6534067.
   PubMed Web of Science ®Google Scholar
• Togliatto G, Dentelli P, Rosso A, et al. PDGF-BB carried by endothelial cell-derived extracellular vesicles reduces vascular smooth muscle cell apoptosis in diabetes. Diabetes. 2018 Apr;674:704–716. PubMed PMID: 29386225
   PubMedGoogle Scholar
• Zhang W, Liu D, Han X, et al. MicroRNA-451 inhibits vascular smooth muscle cell migration and intimal hyperplasia after vascular injury via Ywhaz/p38 MAPK pathway. Exp Cell Res. 2019 Jun 15;379(2):214–224. PubMed PMID: 30930138.
   PubMedGoogle Scholar
• Dong X, Hu H, Fang Z, et al. CTRP6 inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration. Biomed Pharmacother. 2018 Jul;103:844–850. PubMed PMID: 29710500
   PubMed Web of Science ®Google Scholar
• Poller W, Dimmeler S, Heymans S, et al. Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. Eur Heart J. 2018 Aug 1;39(29):2704–2716. PubMed PMID: 28430919; PubMed Central PMCID: PMCPMC6454570.
   PubMed Web of Science ®Google Scholar
• Wang Y, Song X, Li Z, et al. Long non-coding RNAs in coronary atherosclerosis. Life Sci. 2018 Oct 15;211:189–197. PubMed PMID: 30195033.
   PubMed Web of Science ®Google Scholar
• Wu G, Cai J, Han Y, et al. LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation. 2014 Oct 21;130(17):1452–1465. PubMed PMID: 25156994; PubMed Central PMCID: PMCPMC4244705.
   PubMed Web of Science ®Google Scholar
• Shan K, Jiang Q, Wang XQ, et al. Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction. Cell Death Dis. 2016 Jun 2;7(6)e2248. PubMed PMID: 27253412; PubMed Central PMCID: PMCPMC5143375.
   PubMedGoogle Scholar
• Arslan S, Berkan O, Lalem T, et al. Long non-coding RNAs in the atherosclerotic plaque. Atherosclerosis. 2017 Nov;266:176–181. PubMed PMID: 29035780
   PubMed Web of Science ®Google Scholar
• Xu B, Gong X, Zi L, et al. Silencing of DLEU2 suppresses pancreatic cancer cell proliferation and invasion by upregulating microRNA-455. Cancer Sci. 2019 May;110(5):1676–1685. PubMed PMID: 30838724; PubMed Central PMCID: PMCPMC6501038
   PubMed Web of Science ®Google Scholar
• Xie ZZ, Xiao ZC, Song YX, et al. Long non-coding RNA Dleu2 affects proliferation, migration and invasion ability of laryngeal carcinoma cells through triggering miR-16-1 pathway. Eur Rev Med Pharmacol Sci. 2018 Apr;227:1963–1970. PubMed PMID: 29687850
   PubMedGoogle Scholar
• Guo Y, Bai M, Lin L, et al. LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2. Biomed Pharmacother. 2019 Oct;118:109272. PubMed PMID: 31376657
   PubMedGoogle Scholar
• Liu K, Liu C, Zhang Z. lncRNA GAS5 acts as a ceRNA for miR-21 in suppressing PDGF-bb-induced proliferation and migration in vascular smooth muscle cells. J Cell Biochem. 2019 Sep;120(9):15233–15240. PubMed PMID: 31069831.
   PubMed Web of Science ®Google Scholar
• Wang X, Li D, Chen H, et al. Expression of long noncoding RNA LIPCAR promotes cell proliferation, cell migration, and change in phenotype of vascular smooth muscle cells. Med Sci Monit. 2019 Oct 11;25:7645–7651. PubMed PMID: 31603865; PubMed Central PMCID: PMCPMC6800467.
   PubMedGoogle Scholar
• Zhou Y, He X, Liu R, et al. LncRNA CRNDE regulates the proliferation and migration of vascular smooth muscle cells. J Cell Physiol. 2019 Feb 10; PubMed PMID: 30740670. DOI: 10.1002/jcp.28284.
   Google Scholar
• Wang H, Jin Z, Pei T, et al. Long noncoding RNAs C2dat1 enhances vascular smooth muscle cell proliferation and migration by targeting MiR-34a-5p. J Cell Biochem. 2019 Mar;120(3):3001–3008. PubMed PMID: 30474870
   PubMed Web of Science ®Google Scholar
• Zhou Y, Shi H, Du Y, et al. lncRNA DLEU2 modulates cell proliferation and invasion of non-small cell lung cancer by regulating miR-30c-5p/SOX9 axis. Aging (Albany NY). 2019 Sep 20;11(18):7386–7401. PubMed PMID: 31541993; PubMed Central PMCID: PMCPMC6781974.
   PubMedGoogle Scholar
• Deng JH, Zheng GY, Li HZ, et al. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15. Eur Rev Med Pharmacol Sci. 2019 Dec;2324:10699–10707. PubMed PMID: 31858538
   PubMed Web of Science ®Google Scholar
• Qi X, Zhang DH, Wu N, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015 Oct;5210:710–718. PubMed PMID: 26358722
   PubMed Web of Science ®Google Scholar
• Ballantyne MD, McDonald RA, Baker AH. lncRNA/MicroRNA interactions in the vasculature. Clin Pharmacol Ther. 2016 May;99(5):494–501. PubMed PMID: 26910520; PubMed Central PMCID: PMCPMC4881297.
   PubMed Web of Science ®Google Scholar
• Wu DM, Wen X, Han XR, et al.Role of Circular RNA DLEU2 in Human Acute Myeloid Leukemia. Mol Cell Biol. 2018 Oct 15; 38(20). PubMed PMID: 30037980; PubMed Central PMCID: PMCPmc6168983. eng. DOI: 10.1128/mcb.00259-18.
   Google Scholar
• Han S, Qi Y, Xu Y, et al. lncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p. Cancer Cell Int. 2021 Jul 14;21(1):376. PubMed PMID: 34261460.
   PubMed Web of Science ®Google Scholar
• Choe KN, Moldovan GL. Forging ahead through darkness: PCNA, still the principal conductor at the replication fork. Mol Cell. 2017 Feb 2;65(3):380–392. PubMed PMID: 28157503; PubMed Central PMCID: PMCPMC5302417.
   PubMed Web of Science ®Google Scholar
• Arnoldi R, Hiltbrunner A, Dugina V, et al. Smooth muscle actin isoforms: a tug of war between contraction and compliance. Eur J Cell Biol. 2013 Jun-Jul;926–7:187–200. PubMed PMID: 23915964
   PubMedGoogle Scholar
• Salabei JK, Cummins TD, Singh M, et al. PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress. Biochem J. 2013 May 1;451(3):375–388. PubMed PMID: 23421427; PubMed Central PMCID: PMCPMC4040966.
   PubMedGoogle Scholar
• Wang TM, Chen KC, Hsu PY, et al. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype. J Cell Mol Med. 2017 Dec;2112:3592–3601. PubMed PMID: 28699690; PubMed Central PMCID: PMCPMC5706591
   PubMed Web of Science ®Google Scholar